Navigation Links
Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
Date:7/18/2012

BEDFORD, Mass., July 18, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the NVVP (Netherlands Society for Pathology) has approved the use of the Hologic Cervista HPV HR test for detecting human papillomavirus in the Dutch national cervical screening programme.[i]

HPV is one of the most common sexually transmitted diseases (STD) and is recognized as the cause of most cervical cancers. To help prevent the onset of disease, the RIVM (National Institute for Public Health and the Environment in The Netherlands) suggests routine Pap testing and HPV HR triage for ASCUS/LSIL testing for women over the age of 30 to identify women most likely to develop cervical cancer.[ii]

"We are extremely excited to enter the Netherlands Cervical Screening Programme with our Hologic Cervista HPV HR test for detecting HPV," said Rohan Hastie, Ph.D., Hologic Vice President & General Manager of Diagnostics. "The Cervista HPV HR test includes an internal control intended to verify adequate cellularity for testing, thus reducing the potential for false negative results," Dr. Hastie added. "Because it requires a smaller specimen volume, this test may minimize inconclusive or indeterminate results, which may lead to fewer patients being called back for repeat testing. More importantly, the test is designed to minimize false positive results due to a low-risk HPV strain being mistakenly recognized as a high-risk HPV strain, thereby potentially reducing unnecessary clinical management and patient anxiety. The test is built on redundancy and focused on the L1/E6E7 region so it protects against false negative outcomes in the event of L1 deletion."

About the Cervista HPV HR TestThe Cervista HPV HR test is based on Invader chemistry, a patented technology owned by Hologic and well established in other areas of molecular testing. The test utilizes the sample collected with the Hologic ThinPrep Pap test, offering additional convenience for the healthcare provider and the test is integrated to work on the Hologic Cervista MTA (Medium Throughput Automation) system for the extraction of DNA and HPV detection.

About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Hologic, Cervista, Invader, ThinPrep and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Forward-Looking Statement DisclaimerThis News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of the Hologic Cervista HPV HR and ThinPrep Pap tests. There can be no assurance the tests or systems will achieve the benefits described herein and that such benefits will be replicated in any particular manner as the actual effect of the use of the tests and systems can only be determined on a case-by-case basis depending on the particular circumstances and installation in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.

Contacts:Jim Culley, PhD

Diane ScheggetmanCorporate Marketing, Senior Director

Marketing and Sales, ExecutiveHologic, Inc.

Hologic, Inc.Jim.Culley@Hologic.com

Diane.Scheggetman@Hologic.comTel: +1 781 999 7583

Tel: + 31 36 7111186


[i] www.pathology.nl [Netherlands Society for Pathology]
[ii] www.rivm.nl  [National Institute for Public Health and the Environment]


'/>"/>
SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
2. Hologic And Gen-Probe Provide Update On Pending Transaction
3. Hologic, Inc. Announces Note Offering
4. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
5. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
6. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
7. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
8. The Healing Power of Human Milk
9. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
10. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
11. ReproCELL Launches Alzheimers Disease Model Based on iPS-derived Human Neuronal Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016 Quantum Radiology,s Mobile Breast Center ... interpretation directly to women at the workplace, thereby maximizing ... as Delta Air Lines and SunTrust Bank, and community ... component of wellness initiatives. "I think it,s ... enables them to have a mammogram without taking a ...
(Date:12/2/2016)... ALEXANDRIA, Va. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... year by the Academy of Managed Care Pharmacy ... care organizations can better address the opioid addiction ... Medication Assisted Therapies (MAT). ATAG,s newly ... in Improving Access to Naloxone," addresses many issues ...
(Date:12/2/2016)... 2, 2016 CVS Health Corporation (NYSE: ... in New York City on Thursday, December 15, 2016, beginning at 8:00 a.m. ... will provide an in-depth review of the company,s strategies ... company will also discuss 2017 earnings guidance during the ... the event will be broadcast simultaneously on the Investor ...
Breaking Medicine Technology:
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... announces today that they have teamed up with The American College of Surgeons ... the ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot ...
(Date:12/4/2016)... Fl (PRWEB) , ... December 02, 2016 , ... ... that will give patients better access to nutraceuticals and help doctors more efficiently ... EMR patient portal and practice management software platform for Integrative and Functional Medicine. ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... transitions and many more tools allowing FCPX editors to create professional looking video ... Studios. , Perfect Harmony contains a beautifully designed 3D environment for placing ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-Aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... presets that have new attractive animation styles with unique displacement design elements," said ... 30 pre-animated lower third designs. Choose from a variety of design styles that ...
Breaking Medicine News(10 mins):